IBDEI0AL ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4984,1,4,0)
 ;;=4^250.80
 ;;^UTILITY(U,$J,358.3,4984,1,5,0)
 ;;=5^DM Type II with LE Ulcer
 ;;^UTILITY(U,$J,358.3,4984,2)
 ;;=DM Type II with LE Ulcer^267846^707.10
 ;;^UTILITY(U,$J,358.3,4985,0)
 ;;=250.00^^41^479^5
 ;;^UTILITY(U,$J,358.3,4985,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4985,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,4985,1,5,0)
 ;;=5^DM Type II Dm W/O Complications
 ;;^UTILITY(U,$J,358.3,4985,2)
 ;;=^33605
 ;;^UTILITY(U,$J,358.3,4986,0)
 ;;=250.40^^41^479^6
 ;;^UTILITY(U,$J,358.3,4986,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4986,1,4,0)
 ;;=4^250.40
 ;;^UTILITY(U,$J,358.3,4986,1,5,0)
 ;;=5^DM Type II Dm with Nephropathy
 ;;^UTILITY(U,$J,358.3,4986,2)
 ;;=^267837^583.81
 ;;^UTILITY(U,$J,358.3,4987,0)
 ;;=250.50^^41^479^9
 ;;^UTILITY(U,$J,358.3,4987,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4987,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,4987,1,5,0)
 ;;=5^DM Type II w/ PDR
 ;;^UTILITY(U,$J,358.3,4987,2)
 ;;=DM Type II w/ PDR^267839^362.02
 ;;^UTILITY(U,$J,358.3,4988,0)
 ;;=250.60^^41^479^7
 ;;^UTILITY(U,$J,358.3,4988,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4988,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,4988,1,5,0)
 ;;=5^DM Type II Dm with Neuropathy
 ;;^UTILITY(U,$J,358.3,4988,2)
 ;;=^267841^357.2
 ;;^UTILITY(U,$J,358.3,4989,0)
 ;;=250.70^^41^479^8
 ;;^UTILITY(U,$J,358.3,4989,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4989,1,4,0)
 ;;=4^250.70
 ;;^UTILITY(U,$J,358.3,4989,1,5,0)
 ;;=5^DM Type II Dm with Peripheral Vasc Dis
 ;;^UTILITY(U,$J,358.3,4989,2)
 ;;=^267843^443.81
 ;;^UTILITY(U,$J,358.3,4990,0)
 ;;=250.01^^41^479^4
 ;;^UTILITY(U,$J,358.3,4990,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4990,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,4990,1,5,0)
 ;;=5^DM Type I DM W/O Complications
 ;;^UTILITY(U,$J,358.3,4990,2)
 ;;=^33586
 ;;^UTILITY(U,$J,358.3,4991,0)
 ;;=272.0^^41^479^22
 ;;^UTILITY(U,$J,358.3,4991,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4991,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,4991,1,5,0)
 ;;=5^Hypercholesterolemia, Pure
 ;;^UTILITY(U,$J,358.3,4991,2)
 ;;=Hypercholesterolemia, Pure^59973
 ;;^UTILITY(U,$J,358.3,4992,0)
 ;;=272.1^^41^479^28
 ;;^UTILITY(U,$J,358.3,4992,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4992,1,4,0)
 ;;=4^272.1
 ;;^UTILITY(U,$J,358.3,4992,1,5,0)
 ;;=5^Hypertriglyceridemia, Pure
 ;;^UTILITY(U,$J,358.3,4992,2)
 ;;=Hypertriglyceridemia, Pure^101303
 ;;^UTILITY(U,$J,358.3,4993,0)
 ;;=272.2^^41^479^24
 ;;^UTILITY(U,$J,358.3,4993,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4993,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,4993,1,5,0)
 ;;=5^Hyperlipidemia, Mixed
 ;;^UTILITY(U,$J,358.3,4993,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,4994,0)
 ;;=275.42^^41^479^21
 ;;^UTILITY(U,$J,358.3,4994,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4994,1,4,0)
 ;;=4^275.42
 ;;^UTILITY(U,$J,358.3,4994,1,5,0)
 ;;=5^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,4994,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,4995,0)
 ;;=275.41^^41^479^29
 ;;^UTILITY(U,$J,358.3,4995,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4995,1,4,0)
 ;;=4^275.41
 ;;^UTILITY(U,$J,358.3,4995,1,5,0)
 ;;=5^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,4995,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,4996,0)
 ;;=276.7^^41^479^23
 ;;^UTILITY(U,$J,358.3,4996,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4996,1,4,0)
 ;;=4^276.7
 ;;^UTILITY(U,$J,358.3,4996,1,5,0)
 ;;=5^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,4996,2)
 ;;=^60042
 ;;^UTILITY(U,$J,358.3,4997,0)
 ;;=275.2^^41^479^19
 ;;^UTILITY(U,$J,358.3,4997,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4997,1,4,0)
 ;;=4^275.2
 ;;^UTILITY(U,$J,358.3,4997,1,5,0)
 ;;=5^Hyper Or Hypomagnesemia
